Publications by authors named "Hub A E Zwart"
Precision Medicine is driven by the idea that the rapidly increasing range of relatively cheap and efficient self-tracking devices make it feasible to collect multiple kinds of phenotypic data. Advocates of N = 1 research emphasize the countless opportunities personal data provide for optimizing individual health. At the same time, using biomarker data for lifestyle interventions has shown to entail complex challenges.
View Article and Find Full Text PDFArticle Synopsis
- Engineering synthetic cells could change the game in biotechnology and how we solve major global problems.
- We need to consider the socioeconomic factors involved in using synthetic cells to ensure fair benefits for everyone.
- Open public discussions are crucial to align these innovations with societal needs and sustainability goals.
Background: The avalanche of commentaries on CRISPR-Cas9 technology, a bacterial immune system modified to recognize any short DNA sequence, cut it out, and insert a new one, has rekindled hopes for gene therapy and other applications and raised criticisms of engineering genes in future generations.
Sources Of Data: This discussion draws on articles that emphasize ethics, identified partly through PubMed and Google, 2014-2016.
Areas Of Agreement: CRISPR-Cas9 has taken the pace and prospects for genetic discovery and applications to a high level, stoking anticipation for somatic gene engineering to help patients.